Real-world (rw) outcomes to chemoimmunotherapy and biomarker analysis in extensive-stage small cell lung cancer (ES SCLC)

被引:0
|
作者
Panagiotou, E. [1 ]
Livanou, M. E. [1 ]
Montgomery, A. [2 ]
Mastrogeorgiou, M. [1 ]
Moeckel, C. [2 ]
Syrigos, N. [1 ]
Mouratidis, I. [2 ]
Charpidou, A. [1 ]
Georgakopoulos-Soares, I. [2 ]
Vathiotis, I. [1 ]
机构
[1] Sotiria Thorac Dis Hosp Athens, Med Oncol, Athens, Greece
[2] Penn State Coll Med, Biochem & Mol Biol, Hershey, PA USA
关键词
D O I
10.1016/j.annonc.2023.09.1238
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2007P
引用
收藏
页码:S1069 / S1069
页数:1
相关论文
共 50 条
  • [31] Chemoimmunotherapy in patients with extensive-stage small cell lung cancer and a poor performance status
    Agarwal, Muskan
    Liu, Alex
    Almquist, Daniel
    Langlais, Blake T.
    Leventakos, Konstantinos
    Yu, Nathan Y.
    Manochakian, Rami
    Ernani, Vinicius
    CANCER, 2023, 129 (22) : 3546 - 3553
  • [32] Real-World Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Extensive-Stage Small Cell Lung Cancer in Canada
    O'Sullivan, Dylan E.
    Cheung, Winson Y.
    Syed, Iqra A.
    Moldaver, Daniel
    Shanahan, Mary Kate
    Bebb, D. Gwyn
    Sit, Christina
    Brenner, Darren R.
    Boyne, Devon J.
    CURRENT ONCOLOGY, 2021, 28 (04) : 3091 - 3103
  • [33] INTENSIVE CHEMOTHERAPY FOR EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER (SCLC)
    OSOBA, D
    CANCER INVESTIGATION, 1992, 10 (02) : 185 - 186
  • [34] Clinical outcomes and synergistic effect between radiotherapy and immunotherapy in patients with extensive-stage small cell lung cancer: a real-world study
    Sun, Meiling
    Ji, Huaijun
    Deng, Fang
    Li, Jingyi
    Xu, Ning
    Li, Yu
    BMC CANCER, 2024, 24 (01)
  • [35] Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: an integrated clinical and radiomics approach
    Zhao, Jie
    He, Yayi
    Yang, Xue
    Tian, Panwen
    Zeng, Liang
    Huang, Kun
    Zhao, Jing
    Zhou, Jiaqi
    Zhu, Yin
    Wang, Qiyuan
    Chen, Mailin
    Li, Wen
    Gao, Yi
    Zhang, Yongchang
    Xia, Yang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (09)
  • [36] Treating patients with platinum-sensitive extensive-stage small-cell lung cancer in a real-world setting
    Sands, Jacob
    Subramanian, Janakiraman
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [37] The impact of an etoposide shortage on patients with extensive-stage small cell lung cancer (ES-SCLC): Results of a natural experiment
    Browne, C.
    Ayoube, T.
    Samarasinghe, N.
    Hussaini, K.
    Warner, A.
    Black, M.
    Palma, D. A.
    Raphael, J.
    Kuruvilla, M. S.
    Blanchette, P.
    ANNALS OF ONCOLOGY, 2023, 34 : S1065 - S1065
  • [38] Efficacy and safety of integrating consolidative thoracic radiotherapy with immunochemotherapy in extensive-stage small cell lung cancer: a real-world retrospective analysis
    Zhang, Qi
    Wang, Qian
    Wang, Mengsen
    Liu, Xiaomeng
    Han, Dan
    Sun, Hongfu
    Zhao, Chengwei
    Liu, Chengxin
    JOURNAL OF THORACIC DISEASE, 2025, 17 (02)
  • [39] Myeloprotection effects of trilaciclib in Chinese patients with extensive stage small cell lung cancer (ES-SCLC) receiving chemotherapy-a real-world study
    Chen, Yongxing
    Meng, Chong
    Liu, Lirong
    Liu, Kai
    Chen, Tao
    Yang, Chen
    JOURNAL OF THORACIC DISEASE, 2024, 16 (11)
  • [40] Prognostic impact of Neutrophil-to-Lymphocyte Ratio (NLR) For Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
    Ishihara, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S684 - S685